Abstract
Human Gene TherapyVol. 11, No. 10 Clinical Protocol: Phase I Study of Chemokine and Cytokine Gene-Modified Autologous Neuroblastoma Cells for Treatment of Relapsed/Refractory Neuroblastoma Using an Adenoviral Vector.Published Online:6 Jul 2004https://doi.org/10.1089/10430340050057549AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byImmunotherapeutic Strategies for Neuroblastoma: Present, Past and Future13 January 2021 | Vaccines, Vol. 9, No. 1αβ T-cell receptor bias in disease and therapy (Review)18 April 2016 | International Journal of Oncology, Vol. 48, No. 6Polymeric oncolytic adenovirus for cancer gene therapyJournal of Controlled Release, Vol. 219Immunotherapy in pediatric malignancies: current status and future perspectivesFuture Oncology, Vol. 10, No. 9Cellular Immunotherapy of Cancer3 August 2010GentherapieHuman NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice11 April 2007 | Cancer Immunology, Immunotherapy, Vol. 56, No. 11Cellular immune response to an engineered cell-based tumor vaccine at the vaccination siteCellular Immunology, Vol. 245, No. 2The evolving role of gene-based treatment in surgery4 November 2005 | British Journal of Surgery, Vol. 92, No. 12A distinct “side population” of cells with high drug efflux capacity in human tumor cells20 September 2004 | Proceedings of the National Academy of Sciences, Vol. 101, No. 39Low-dose interferon-γ-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity4 May 2004 | British Journal of Cancer, Vol. 90, No. 11Restimulation of tumour-specific immunity in a patient with AML following injection with B7-1 positive autologous blastsLeukemia Research, Vol. 27, No. 11Advances in the Diagnosis and Treatment of Neuroblastoma1 June 2003 | The Oncologist, Vol. 8, No. 3Immunothérapie génique du cancerTransfusion Clinique et Biologique, Vol. 9, No. 5-6Novel products of the HUD , HUC , NNP-1 and α-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library3 July 2002 | International Journal of Cancer, Vol. 100, No. 6Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: Phase II randomized study comparing two dose levels12 March 2002 | Cancer Gene Therapy, Vol. 9, No. 3Adenoviral Mediated Interleukin-2 Gene Transfer to Human Long-term Bone Marrow Stromal Cultures Christine Hicks, Elizabeth Keoshkerian, Rosemary French, and Robert Lindeman5 July 2004 | Cancer Biotherapy & Radiopharmaceuticals, Vol. 16, No. 6Immunology and Immunotherapy Volume 11Issue 10Jul 2000 To cite this article:Clinical Protocol: Phase I Study of Chemokine and Cytokine Gene-Modified Autologous Neuroblastoma Cells for Treatment of Relapsed/Refractory Neuroblastoma Using an Adenoviral Vector..Human Gene Therapy.Jul 2000.1477-1488.http://doi.org/10.1089/10430340050057549Published in Volume: 11 Issue 10: July 6, 2004PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
